Latest Media Releases

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Lepidico - Caesium product development expands offtake options (ASX:LPD)

Caesium sulphate process refined to make catalyst quality chemicals Strong demand for caesium carbonate and hydroxide has led Lepidico to leverage its pioneering L-Max® work to develop proces...read more

Lepidico - Phase 1 plant site secured in KIZAD (ASX:LPD)

Lepidico Ltd (ASX:LPD) (“Lepidico” or “Company”) is pleased to announce that the Musataha Agreement with Abu Dhabi Ports Company PJSC has been executed securing the land for ...read more

Lepidico - Path to best-in-class CO2 emissions intensity (ASX:LPD)

Opportunities identified for material reductions in Scope 1 & 2 greenhouse gas emissions from already relatively low levels, with potential to be best-in-class at 3t CO2-e/t LCE Water consump...read more

Lepidico - Lithium offtake interest broadens as deep market deficits predicted (ASX:LPD)

2025’s lithium deficit is expected to exceed the industry’s total output in 2016, according to Benchmark Mineral Intelligence Lepidico is in discussion with eight potential buyers o...read more

LBT Innovations - CCS Appoints Thermo Fisher as Exclusive US APAS Distributor (ASX:LBT)

Australian medical technology company LBT Innovations Limited (ASX: LBT) (LBT or the Company), a leader in medical technology automation using artificial intelligence, is pleased to announce the sig...read more

Lepidico - Full Year Statutory Accounts (ASX:LPD)

Lepidico Ltd (ASX:LPD) (“Lepidico” or “Company”) is pleased to announce the release of its audited consolidated financial statements for the year ended 30 June 2021. Highl...read more

Lepidico - Corporate Presentation Update (ASX:LPD)

To view the presentation, download the attached PDF.

LBT Innovations - Appendix 4E and Annual Financial Statements (ASX:LBT)

To view the appendix, download the attached PDF.

Lepidico - Initiation of coverage by Shaw and Partners (ASX:LPD)

Highlights Lepidico has developed proprietary technology (L-Max® & LOH MaxTM) to produce lithium hydroxide from mica minerals. The company is intending to start with a relatively small s...read more

LBT Innovations - Quarterly Activities/Appendix 4C Cash Flow Report (ASX:LBT)

Highlights for the Quarter Two APAS® Independence instruments sold in the UK to Health Services Laboratory US multi-laboratory purchasing opportunities - AdventHealth and Vizient EU Urin...read more

Lepidico - Quarterly Activities/Appendix 5B Cash Flow Report (ASX:LPD)

Key Points Development Phase 1 Project transitioned to the development phase in May, a major milestone Lycopodium started Stage 1 EPCM works for the vertically integrated Phase 1 Project fl...read more

Lepidico - Low emissions intensity for Phase 1 Chemical Plant (ASX:LPD)

Highlights: -- Emissions intensity associated with the Phase 1 Chemical Plant is low compared with other lithium hydroxide production facilities -- Substantial Scope 3 emissions savings identifi...read more

Lepidico - Appendices 3Y x2 (ASX:LPD)

To view the Change of Director’s Interest Notice, download the attached PDF.

Lepidico - Clarification of supplementary prospectus disclosure (ASX:LPD)

Lepidico Ltd (ASX: LPD) (Lepidico or the Company) refers to the Supplementary Prospectus lodged with ASIC, and released to ASX, on 15 June 2021. It has come to the Company’s attention that ...read more